BMS-P5 free base
BMS-P5 free base is a specific and orally active peptidylarginine deiminase 4 (PAD4) inhibitor. BMS-P5 Blocks Formation of Neutrophil Extracellular Traps and Delays Progression of Multiple Myeloma. Administration of BMS-P5 to multiple myeloma-bearing mice delays appearance of symptoms and disease progression Targeting PAD4 may be beneficial for treatment of multiple myeloma.
| Catalog Number | T22277L |
| Research Area | Chromatin/Epigenetic |
| Molecular Formula | C27H32N6O2 |
| CAS# | 1550371-22-6 |
| Purity | 99.96% |
| SMILES | O=C(N1[C@@H](C)CC[C@@H](N)C1)C2=CC(OC)=C3C(N=C(C4=CC5=CC=CN=C5N4CC6CC6)N3C)=C2 |
| Size | 5 mg |
| Supplier Page | https://www.targetmol.com/compound/BMS-P5 free base |
| Additional Information | https://www.targetmol.com/datasheet/T22277L |